URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Deepak Sahasrabudhe

Concepts (217)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antigens, Neoplasm
5
1987
107
0.880
Why?
Polymorphism, Single Nucleotide
2
2010
84
0.750
Why?
Tissue Kallikreins
1
2010
11
0.730
Why?
Prostatic Neoplasms
3
2008
556
0.640
Why?
T-Lymphocytes, Cytotoxic
2
2001
122
0.550
Why?
HLA Antigens
1
2006
99
0.540
Why?
Receptors, Antigen, T-Cell
1
2006
68
0.540
Why?
Leukemia, Myeloid
1
2006
122
0.530
Why?
Colonic Neoplasms
2
1999
123
0.500
Why?
Antigens, Differentiation, Myelomonocytic
1
2003
26
0.450
Why?
Immune Tolerance
4
1986
144
0.450
Why?
Receptor, Epidermal Growth Factor
1
2003
95
0.420
Why?
Vascular Endothelial Growth Factor A
1
2003
206
0.400
Why?
Antigens, CD
1
2003
245
0.390
Why?
Organ Transplantation
1
2000
11
0.380
Why?
Lymphoproliferative Disorders
1
2000
29
0.380
Why?
Antigens, CD20
1
2000
24
0.370
Why?
T-Lymphocytes, Regulatory
3
1987
50
0.350
Why?
Sarcoma
2
2008
63
0.340
Why?
T-Lymphocytes
4
1986
545
0.330
Why?
Carcinoma, Renal Cell
2
1986
55
0.310
Why?
Kidney Neoplasms
2
1986
102
0.300
Why?
Neoplasms, Second Primary
2
2008
124
0.280
Why?
Middle Aged
12
1981
9877
0.270
Why?
Prognosis
4
1981
1080
0.270
Why?
Immunotherapy, Active
2
1990
4
0.270
Why?
Aged
12
1981
7272
0.270
Why?
Interferon-alpha
1
1994
81
0.240
Why?
Interferon-beta
1
1994
63
0.240
Why?
Neoplasms, Experimental
1
1994
138
0.240
Why?
Neoadjuvant Therapy
2
2008
32
0.240
Why?
Hypersensitivity, Delayed
2
1986
49
0.230
Why?
Genetic Markers
2
2010
132
0.230
Why?
Humans
22
1981
36400
0.220
Why?
Lung Neoplasms
3
1992
428
0.220
Why?
Raynaud Disease
1
1992
6
0.220
Why?
Paraneoplastic Syndromes
1
1992
12
0.210
Why?
Male
13
1981
19713
0.210
Why?
Spermatozoa
1
2012
35
0.210
Why?
Genotype
2
2010
487
0.210
Why?
Deferoxamine
1
1991
17
0.200
Why?
Urinary Bladder Neoplasms
2
2005
173
0.200
Why?
Deoxycytidine
1
2011
28
0.200
Why?
Androgen Antagonists
1
2012
65
0.200
Why?
Cisplatin
1
2011
94
0.190
Why?
Aged, 80 and over
4
2005
2513
0.190
Why?
Radiosurgery
1
2011
74
0.180
Why?
Retrospective Studies
5
1990
2260
0.180
Why?
Disease-Free Survival
1
2010
202
0.170
Why?
Alleles
1
2010
202
0.170
Why?
Adult
8
1986
11345
0.170
Why?
Breast Neoplasms
2
2004
675
0.160
Why?
Soft Tissue Neoplasms
1
2008
46
0.160
Why?
Amino Acid Sequence
3
2001
1231
0.150
Why?
Graft vs Host Disease
1
2008
81
0.150
Why?
Recurrence
1
2010
697
0.150
Why?
Interferon Type I
1
1987
38
0.150
Why?
Cimetidine
1
1987
8
0.150
Why?
Mice, Inbred BALB C
4
1987
621
0.150
Why?
Female
12
1986
19826
0.150
Why?
Bone Marrow Transplantation
1
2008
186
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2011
430
0.150
Why?
Skin Diseases
1
2008
119
0.150
Why?
Leukemia, Myeloid, Acute
1
2008
179
0.140
Why?
Urologic Neoplasms
1
2005
10
0.130
Why?
Tumor Cells, Cultured
3
1993
863
0.130
Why?
Quinolones
1
2005
27
0.130
Why?
Acute Disease
2
1983
580
0.130
Why?
Dinitrofluorobenzene
3
1987
7
0.130
Why?
Carcinoma, Transitional Cell
1
2005
53
0.130
Why?
Neoplasm Proteins
1
2006
181
0.130
Why?
Tumor Markers, Biological
1
2006
228
0.120
Why?
Molecular Sequence Data
2
2006
2028
0.120
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.120
Why?
Mice
6
1987
6103
0.120
Why?
CD8-Positive T-Lymphocytes
1
2006
221
0.120
Why?
Cytotoxicity, Immunologic
2
1993
110
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2004
51
0.120
Why?
Hot Flashes
1
2004
28
0.120
Why?
Acetates
1
2004
65
0.120
Why?
Cell Line, Tumor
1
2006
576
0.120
Why?
Tamoxifen
1
2004
84
0.110
Why?
Cyclohexanecarboxylic Acids
1
2004
47
0.110
Why?
Amines
1
2004
63
0.110
Why?
Neoplasm Metastasis
2
1986
229
0.110
Why?
Angiogenesis Inducing Agents
1
2003
13
0.110
Why?
gamma-Aminobutyric Acid
1
2004
98
0.110
Why?
Enzyme Inhibitors
1
2005
438
0.110
Why?
Dendritic Cells
1
2004
121
0.110
Why?
Adenoviridae
1
2003
128
0.110
Why?
Colorectal Neoplasms
1
2004
136
0.110
Why?
Macrophages
1
2004
347
0.100
Why?
Genes, Lethal
1
2001
12
0.100
Why?
Melanoma
1
2003
135
0.100
Why?
Immunoglobulins
1
1981
74
0.100
Why?
Interferon-gamma
1
2003
345
0.100
Why?
Multiple Myeloma
1
1981
76
0.100
Why?
Multivariate Analysis
1
2003
531
0.100
Why?
Cell Division
2
1991
766
0.090
Why?
Animals
7
1987
16270
0.090
Why?
Herpesvirus 4, Human
1
2000
62
0.090
Why?
Intestine, Small
1
2000
111
0.090
Why?
Chemotherapy, Adjuvant
2
2008
88
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2000
132
0.090
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
78
0.090
Why?
Antineoplastic Agents
1
2005
625
0.090
Why?
Cancer Vaccines
1
1999
29
0.090
Why?
Time Factors
3
1983
3201
0.080
Why?
Recombinant Proteins
1
2001
768
0.080
Why?
Treatment Outcome
4
1999
2623
0.080
Why?
Rectal Neoplasms
1
1999
83
0.080
Why?
Interleukin-1
1
1999
222
0.080
Why?
Liver Transplantation
1
2000
238
0.080
Why?
Skin Tests
3
1987
27
0.080
Why?
Medical Oncology
1
1997
49
0.070
Why?
Fellowships and Scholarships
1
1997
53
0.070
Why?
Adenocarcinoma
2
1992
423
0.070
Why?
Geriatrics
1
1997
68
0.070
Why?
Cyclophosphamide
2
1986
173
0.070
Why?
Antibodies, Monoclonal
1
2000
732
0.070
Why?
Postoperative Complications
1
2000
743
0.070
Why?
Plasmacytoma
1
1994
10
0.060
Why?
Mice, Inbred DBA
1
1994
88
0.060
Why?
Infant
1
2000
2249
0.060
Why?
HLA-A2 Antigen
1
1993
9
0.060
Why?
Histocompatibility Antigens Class I
1
1994
94
0.060
Why?
Gene Products, gag
1
1993
16
0.060
Why?
Administration, Oral
2
2004
309
0.060
Why?
DNA, Complementary
2
2001
261
0.060
Why?
RNA, Messenger
1
2000
1857
0.060
Why?
Histocompatibility Antigens Class II
1
1994
190
0.060
Why?
Amputation
1
1992
24
0.050
Why?
Genetic Association Studies
1
2012
19
0.050
Why?
tRNA Methyltransferases
1
2012
19
0.050
Why?
Immunohistochemistry
2
2004
1063
0.050
Why?
Treatment Failure
1
2012
130
0.050
Why?
Fingers
1
1992
69
0.050
Why?
Child
1
2000
4086
0.050
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.050
Why?
Ferric Compounds
1
1991
25
0.050
Why?
Sarcoma, Synovial
1
2011
7
0.050
Why?
Leiomyosarcoma
1
2011
18
0.050
Why?
Immunosuppression
1
1991
64
0.050
Why?
Liver Neoplasms
1
1992
152
0.050
Why?
Chlorides
1
1991
121
0.050
Why?
Radiotherapy Dosage
1
2011
203
0.050
Why?
Genetic Vectors
2
2001
339
0.040
Why?
Prospective Studies
2
2004
1677
0.040
Why?
Predictive Value of Tests
1
2012
601
0.040
Why?
Survivors
1
2011
114
0.040
Why?
Radiation Injuries
1
2011
130
0.040
Why?
Abdominal Neoplasms
1
2008
17
0.040
Why?
Biopsy, Fine-Needle
1
2008
21
0.040
Why?
Carcinoid Tumor
1
2008
26
0.040
Why?
Adenoma
1
2008
53
0.040
Why?
Pituitary Neoplasms
1
2008
66
0.040
Why?
Radiotherapy, Adjuvant
1
2008
73
0.040
Why?
Cohort Studies
1
2011
969
0.040
Why?
Antigens
1
1987
99
0.040
Why?
Diphenhydramine
1
1987
9
0.040
Why?
Transplantation, Homologous
1
2008
260
0.040
Why?
Hybrid Cells
1
1987
26
0.040
Why?
Immunization, Passive
1
1987
64
0.040
Why?
Skin
1
1990
381
0.040
Why?
Antigens, Surface
1
1987
101
0.040
Why?
Cells, Cultured
1
1993
2563
0.040
Why?
Immunotherapy
1
1986
88
0.030
Why?
Spleen
1
1987
339
0.030
Why?
Chronic Disease
1
2008
530
0.030
Why?
Young Adult
1
2011
1074
0.030
Why?
Receptor, erbB-2
1
2006
68
0.030
Why?
Urothelium
1
2005
20
0.030
Why?
Exanthema
1
2005
12
0.030
Why?
Diarrhea
1
2005
64
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2006
148
0.030
Why?
Remission Induction
1
2005
163
0.030
Why?
Neutropenia
1
2005
57
0.030
Why?
Eosinophils
1
2004
51
0.030
Why?
Microsatellite Repeats
1
2004
45
0.030
Why?
Arabinofuranosyluracil
1
1983
2
0.030
Why?
Mast Cells
1
2004
47
0.030
Why?
Tomography, X-Ray Computed
1
2008
765
0.030
Why?
Cytarabine
1
1983
91
0.030
Why?
Uridine
1
1983
36
0.030
Why?
Risk Assessment
1
2008
878
0.030
Why?
Injections, Intralesional
1
2003
12
0.030
Why?
Killer Cells, Natural
1
2004
119
0.030
Why?
beta 2-Microglobulin
1
2003
19
0.030
Why?
Leukemia
1
1983
154
0.030
Why?
Pilot Projects
1
2004
441
0.030
Why?
Survival Analysis
1
2004
598
0.030
Why?
Adolescent
1
2011
4752
0.020
Why?
Risk Factors
1
2008
2318
0.020
Why?
Ribosomal Proteins
1
2001
40
0.020
Why?
Vaccinia virus
1
2001
53
0.020
Why?
Interleukin-6
1
2003
340
0.020
Why?
Neoplasms
1
1987
723
0.020
Why?
Follow-Up Studies
1
2005
1857
0.020
Why?
Hepatitis B Antibodies
1
1999
12
0.020
Why?
Severity of Illness Index
1
2004
919
0.020
Why?
Lipid A
1
1999
10
0.020
Why?
Mycobacterium
1
1999
8
0.020
Why?
Adjuvants, Immunologic
1
1999
120
0.020
Why?
Base Sequence
1
2001
1704
0.020
Why?
Gene Expression Regulation
1
2001
875
0.020
Why?
Cell Fusion
1
1987
25
0.010
Why?
DNA, Neoplasm
1
1987
123
0.010
Why?
HeLa Cells
1
1987
297
0.010
Why?
Vaccination
1
1987
241
0.010
Why?
Flow Cytometry
1
1987
597
0.010
Why?
Nucleoside Deaminases
1
1983
9
0.010
Why?
Radioimmunoassay
1
1983
113
0.010
Why?
Infusions, Parenteral
1
1983
70
0.010
Why?
Chromatography, High Pressure Liquid
1
1983
210
0.010
Why?
Dose-Response Relationship, Drug
1
1983
1138
0.010
Why?
Kinetics
1
1983
1464
0.010
Why?
Models, Biological
1
1983
1023
0.010
Why?

Visualizations


Sahasrabudhe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department